Computer Science · Computer Networks and Communications
Acute cholestatic hepatitis along with agranulocytosis: A rare side\neffect of carbimazole
Jain, Karun, Chakrapani, M., Smitha, K.
See on the mapAbstract
Antithyroid drugs have been used for more than 50 years for the\nmanagement of hyperthyroidism. Most patients tolerate treatment well\nbut some may develop life-threatening side effects such as\nagranulocytosis, aplastic anemia and cholestatic hepatitis. A\n45-year-old female was diagnosed with severe hyperthyroidism. Treatment\nwith Carbimazole 30 mg/day was initiated. Within six weeks following\nthe start of therapy, patient developed potentially life-threatening\nacute cholestatic hepatitis and agranulocytosis as adverse effects to\ncarbimazole. The patient′s symptoms and laboratory abnormalities\nresolved following withdrawal of offending drug. Agranulocytosis and\ncholestatic hepatitis together is an extremely rare idiosyncratic side\neffect of Carbimazole treatment and considered to be dose and\nage-related. Antithyroid drugs are deceptively easy to use, but because\nof the variability in the response of patients and the potentially\nserious side effects, all practitioners who prescribe the drugs need to\nhave a working knowledge of their complex pharmacology.